Yes, thank you.
Thank you, Madam Chair, and thank you to the committee for allowing the IMC to speak to you today.
I would just add—and this was already touched upon by some of the witnesses to the committee—that the issue of regulatory barriers and impediments to international supply chains is right now a clear and present danger. Canada has directly experienced this in the context of the European Union and some of the measures the EU has undertaken. Fortunately, and partially because of the great work of officials at Global Affairs Canada, this hasn't been a significant issue for Canada, but it has been for other nations.
Impediments to global supply chains are certainly a significant issue. Regulatory co-operation, in terms of recognition of vaccines, is also a very important issue that needs to be addressed.